Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis.
Chavoustie SE, Carter BA, Waldbaum AS, Donders GGG, Peters KH, Schwebke JR, Paull JRA, Price CF, Castellarnau A, McCloud P, Kinghorn GR. Chavoustie SE, et al. Among authors: schwebke jr. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:13-18. doi: 10.1016/j.ejogrb.2019.11.032. Epub 2019 Nov 28. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31812702 Free article. Clinical Trial.
A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis.
Chavoustie SE, Gersten JK, Samuel MJ, Schwebke JR. Chavoustie SE, et al. Among authors: schwebke jr. J Womens Health (Larchmt). 2018 Apr;27(4):492-497. doi: 10.1089/jwh.2017.6500. Epub 2018 Jan 11. J Womens Health (Larchmt). 2018. PMID: 29323627 Clinical Trial.
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis.
Waldbaum AS, Schwebke JR, Paull JRA, Price CF, Edmondson SR, Castellarnau A, McCloud P, Kinghorn GR. Waldbaum AS, et al. Among authors: schwebke jr. PLoS One. 2020 May 4;15(5):e0232394. doi: 10.1371/journal.pone.0232394. eCollection 2020. PLoS One. 2020. PMID: 32365097 Free PMC article. Clinical Trial.
Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
Muzny CA, Schwebke JR, Nyirjesy P, Kaufman G, Mena LA, Lazenby GB, Van Gerwen OT, Graves KJ, Arbuckle J, Carter BA, McMahon CP, Eder S, Shaw J, Pandey B, Chavoustie SE. Muzny CA, et al. Among authors: schwebke jr. Clin Infect Dis. 2021 Sep 15;73(6):e1282-e1289. doi: 10.1093/cid/ciab242. Clin Infect Dis. 2021. PMID: 33768237 Free PMC article. Clinical Trial.
Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study.
Schwebke JR, Taylor SN, Ackerman R, Schlaberg R, Quigley NB, Gaydos CA, Chavoustie SE, Nyirjesy P, Remillard CV, Estes P, McKinney B, Getman DK, Clark C. Schwebke JR, et al. J Clin Microbiol. 2020 Jan 28;58(2):e01643-19. doi: 10.1128/JCM.01643-19. Print 2020 Jan 28. J Clin Microbiol. 2020. PMID: 31748322 Free PMC article.
201 results